- Celina Tretter
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Niklas Andrade Krätzig
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IInd Medical Department
Technical University of Munich, TUM School of Medicine, Center for Translational Cancer Research (TranslaTUM)
Technical University of Munich, TUM School of Medicine, Institute of Molecular Oncology and Functional Genomics)
- Matteo Pecoraro
(Max Plank Institute of Biochemistry
Università della Svizzera italiana)
- Sebastian Lange
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IInd Medical Department
Technical University of Munich, TUM School of Medicine, Center for Translational Cancer Research (TranslaTUM)
Technical University of Munich, TUM School of Medicine, Institute of Molecular Oncology and Functional Genomics)
- Philipp Seifert
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Clara Frankenberg
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Johannes Untch
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Gabriela Zuleger
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Mathias Wilhelm
(Technical University of Munich, TUM School of Life Sciences, Chair of Proteomics and Bioanalytics
Technical University of Munich, TUM School of Life Sciences, Computational Mass Spectrometry)
- Daniel P. Zolg
(Technical University of Munich, TUM School of Life Sciences, Chair of Proteomics and Bioanalytics)
- Florian S. Dreyer
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Eva Bräunlein
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Thomas Engleitner
(Technical University of Munich, TUM School of Medicine, Center for Translational Cancer Research (TranslaTUM)
Technical University of Munich, TUM School of Medicine, Institute of Molecular Oncology and Functional Genomics)
- Sebastian Uhrig
(German Cancer Consortium (DKTK), partner site Heidelberg and German Cancer Research Center (DKFZ)
Molecular Precision Oncology Program, NCT Heidelberg)
- Melanie Boxberg
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Institute of Pathology)
- Katja Steiger
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Institute of Pathology)
- Julia Slotta-Huspenina
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Institute of Pathology)
- Sebastian Ochsenreither
(German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ)
Charité – Universitätsmedizin Berlin
Charité – Universitätsmedizin Berlin)
- Nikolas Bubnoff
(German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ)
University of Freiburg
University of Schleswig Holstein, Campus Lübeck)
- Sebastian Bauer
(German Cancer Consortium (DKTK), partner site Essen and German Cancer Research Center (DKFZ)
University Hospital Essen)
- Melanie Boerries
(German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ)
University of Freiburg)
- Philipp J. Jost
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department
Medical University of Graz
University Comprehensive Cancer Center Graz, Medical University of Graz)
- Kristina Schenck
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Iska Dresing
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Florian Bassermann
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department
Technical University of Munich, TUM School of Medicine, Center for Translational Cancer Research (TranslaTUM))
- Helmut Friess
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Department of Surgery)
- Daniel Reim
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Department of Surgery)
- Konrad Grützmann
(German Cancer Consortium (DKTK), partner site Dresden and German Cancer Research Center (DKFZ)
Core Unit Molecular Tumor Diagnostics (CMTD), NCT Dresden
Faculty of Medicine, TU Dresden)
- Katrin Pfütze
(German Cancer Consortium (DKTK), partner site Heidelberg and German Cancer Research Center (DKFZ))
- Barbara Klink
(German Cancer Consortium (DKTK), partner site Dresden and German Cancer Research Center (DKFZ)
Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden)
- Evelin Schröck
(German Cancer Consortium (DKTK), partner site Dresden and German Cancer Research Center (DKFZ)
Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden
ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden
National Center for Tumor Diseases Dresden (NCT/UCC))
- Bernhard Haller
(Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Institute of AI and Informatics in Medicine)
- Bernhard Kuster
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Life Sciences, Chair of Proteomics and Bioanalytics
Technical University of Munich, TUM School of Life Sciences, Bavarian Biomolecular Mass Spectrometry Center (BayBioMS))
- Matthias Mann
(Max Plank Institute of Biochemistry)
- Wilko Weichert
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Institute of Pathology)
- Stefan Fröhling
(German Cancer Consortium (DKTK), partner site Heidelberg and German Cancer Research Center (DKFZ)
German Cancer Research Center (DKFZ))
- Roland Rad
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IInd Medical Department
Technical University of Munich, TUM School of Medicine, Center for Translational Cancer Research (TranslaTUM)
Technical University of Munich, TUM School of Medicine, Institute of Molecular Oncology and Functional Genomics)
- Michael Hiltensperger
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department)
- Angela M. Krackhardt
(German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ)
Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department
Technical University of Munich, TUM School of Medicine, Center for Translational Cancer Research (TranslaTUM)
Malteser Krankenhaus St. Franziskus-Hospital)